Caractérisation moléculaire des adénomes hépatocellulaires

Caractérisation moléculaire des adénomes hépatocellulaires

Les adénomes hépatocellulaires (AHC) sont des tumeurs bénignes rares qui se développent le plus souvent chez la femme jeune suite à la prise de contraceptifs oraux. Les complications principales sont l’hémorragie et plus rarement, la transformation maligne en carcinome hépatocellulaire (CHC). Des tr...

Full description

Bibliographic Details
Main Author:	Pilati, Camilla
Other Authors:	Paris 5
Language:	fr
Published:	2013
Subjects:	Adénome hépatocellulaire JAK/STAT Gp130 STAT3 GNAS FRK JAK1 CTNNB1 TERT Transformation maligne Carcinome hépatocellulaire Hepatocellular adenoma Malignant transformation Hepatocellular carcinoma 616.993
Online Access:	http://www.theses.fr/2013PA05S011

Similar Items

Identification de nouveaux mécanismes de carcinogénèse et facteurs pronostiques des tumeurs hépatocellulaires
by: Nault, Jean-Charles
Published: (2015)

Role of telomerase and β-catenin aberrant activation in benign and malignant liver tumorigenesis
by: Franconi, Andrea
Published: (2017)

Caractérisation moléculaire des adénomes hépatocytaires et des lésions prénéoplasiques hépatiques
by: Calderaro, Julien
Published: (2014)

Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris
by: Farag AGA, et al.
Published: (2019-07-01)

Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo
by: Samaka RM, et al.
Published: (2019-06-01)

Phosphorylated Forms of STAT1, STAT3 and STAT5 Are Expressed in Proliferating but Not Involuted Infantile Hemangioma
by: Lucy Sulzberger, et al.
Published: (2018-04-01)

Effects of Fyn-related kinase activity on breast cancer cell proliferation, migration, invasion and colony formation
Published: (2015)

Loss of JAK1 Drives Innate Immune Deficiency
by: Agnieszka Witalisz-Siepracka, et al.
Published: (2019-01-01)

Ekspresja kinazy Jak3 i aktywacja białka Stat3 u chorych na reumatoidalne zapalenie stawów i spondyloartropatie zapalne
by: Andrzej Steciwko, et al.
Published: (2010-08-01)

STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
by: Ashley A. Able, et al.
Published: (2017-03-01)

STAT3 Dysregulation in Mature T and NK Cell Lymphomas
by: Angelina Seffens, et al.
Published: (2019-11-01)

Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
by: Nicholas P. D. Liau, et al.
Published: (2019-11-01)

Mechanosignaling through Caveolae : A New Role for the Control of JAK-STAT Signaling
by: Tardif, Nicolas
Published: (2018)

TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance
by: Zonghui Ding, et al.
Published: (2020-09-01)

Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
by: Juliane Lokau, et al.
Published: (2019-11-01)

Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
by: Xue Hu, et al.
Published: (2021-04-01)

The commercially available STAT3 inhibitor 5,15-diphenylporphyrin (5,15-DPP) does not directly interact with STAT3 core residues 127–722
by: Siphokazi Sinethemba Mtwebana, et al.
Published: (2020-07-01)

Overexpression of Suppressors of Cytokine Signaling 1 Promotes the Neuronal Differentiation of C17.2 Neural Stem Cells
by: Meng Cui, et al.
Published: (2014-02-01)

Role of janus kinase inhibitors in the treatment of alopecia areata
by: Triyangkulsri K, et al.
Published: (2018-07-01)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01)

STATs: An Old Story, Yet Mesmerizing
by: Abroun Saeid, et al.
Published: (2016-07-01)

Falciparum malaria-induced secondary hemophagocytic lymphohistiocytosis successfully treated with ruxolitinib
by: André Fuchs, et al.
Published: (2020-11-01)

Canonical and non-canonical JAK/STAT transcriptional targets may be involved in distinct and overlapping cellular processes
by: Amy Tsurumi, et al.
Published: (2017-09-01)

Pain in Rheumatoid Arthritis: Could JAK Inhibition be the Answer?
by: Puja Mehta, et al.
Published: (2020-01-01)

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
by: Napolitano M, et al.
Published: (2021-03-01)

JAK2 Inhibition by Fedratinib Reduces Osteoblast Differentiation and Mineralisation of Human Mesenchymal Stem Cells
by: Nihal AlMuraikhi, et al.
Published: (2021-01-01)

Charakterisierung von Punktmutanten in der Linker-Domäne des humanen STAT1-Proteins
by: Grebe, Jessica
Published: (2016)

STIP1 Regulates Proliferation and Migration of Lung Adenocarcinoma Through JAK2/STAT3 Signaling Pathway
by: Guo X, et al.
Published: (2019-11-01)

Interactions and Feedbacks in E-Cadherin Transcriptional Regulation
by: Miguel Ramirez Moreno, et al.
Published: (2021-06-01)

Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review
by: Stefan Siedlikowski, et al.
Published: (2019-11-01)

CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway
by: Xitao Liu, et al.
Published: (2021-07-01)

Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
by: Klara Klein, et al.
Published: (2021-05-01)

IRF-1 expressed in the inner cell mass of the porcine early blastocyst enhances the pluripotency of induced pluripotent stem cells
by: Bingbo Shi, et al.
Published: (2020-11-01)

Blockade of JAK2 signaling produces immunomodulatory effect to preserve pancreatic homeostasis in severe acute pancreatitis
by: Zhaolei Qiu, et al.
Published: (2021-12-01)

Temporal Activation of the JAK-STAT Pathway in Relation to Cardiac Gene Expression in a Mouse Model of Cardiac Dysfunction
by: Talerico, Cassandra
Published: (2007)

Emerin Represses STAT3 Signaling through Nuclear Membrane-Based Spatial Control
by: Byongsun Lee, et al.
Published: (2021-06-01)

The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
by: Alexander Ou, et al.
Published: (2021-01-01)

CEP55 Promotes Cell Motility via JAK2–STAT3–MMPs Cascade in Hepatocellular Carcinoma
by: Minjing Li, et al.
Published: (2018-08-01)

Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling
by: Hao Wang, et al.
Published: (2021-02-01)

RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer
by: Chuanyu Cheng, et al.
Published: (2020-08-01)